GALIMBERTI, FEDERICA
GALIMBERTI, FEDERICA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National Lipigen Registry
2025 L. D'Erasmo, D. Tramontano, A. Di Costanzo, M. Casula, F. Galimberti, F. Baratta, A.B. Cefalù, P. Tarugi, S. Calandra, A. Zambon, M. Averna, A.L. Catapano, M. Arca, G. Banderali, A. Bartuli, G. Beccuti, A. Benso, V. Bianconi, S. Bini, M. Biolo, P. Sabrina Buonuomo, S. D'Addato, B. Dal Pino, M. Di Minno, M. Donata Di Taranto, G. Fainelli, F. Giuliana, A. Giammanco, L. Grigore, G. Iannuzzo, J. Lago, S. Lugari, G. Mandraffino, I. Minicocci, G. Mombelli, T. Montalcini, F. Nascimbeni, D. Noto, C. Pavanello, C. Pederiva, F. Pellegatta, S. Piro, M. Pirro, A. Pujia, L. Rizzi, F. Sbrana, R. Scicali, P. Suppressa, A. Toscano, S. Zambon, M. Grazia Zenti
Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study
2025 M. Casula, S. Scotti, F. Galimberti, G. Matteo Bruno, G. Lorenzo Colombo, A. Alieva, S. Xie, A.L. Catapano, E. Olmastroni
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases
2025 S. Scotti, L. Scotti, F. Galimberti, S. Xie, M. Casula, E. Olmastroni
Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study
2025 E. Olmastroni, J.L. Katzmann, F. Galimberti, U. Laufs, A.L. Catapano
Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials
2025 S. Xie, F. Galimberti, E. Olmastroni, A.L. Catapano, M. Casula
Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk
2025 F. Galimberti, E. Olmastroni, M. Casula, S. Xie, A.L. Catapano
Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review
2024 A. Rossi, L. Perrella, S. Scotti, E. Olmastroni, F. Galimberti, I. Ardoino, V. Orlando, E. Menditto, C. Franchi, M. Casula
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials
2024 S. Xie, F. Galimberti, E. Olmastroni, T.F. Luscher, S. Carugo, A.L. Catapano, M. Casula, C. Wanner, S. Yusuf, A. Maggioni, A. Kirby, H. Ogawa, E.K. Hoogeveen, I. Seljeflot, K. Welty, M. Benderly, J.E. Manson, K. Wolski, C.P. Cannon, F.J. Raal, D. Kallend, J. Foody, M. Louie
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries
2024 A. Alieva, A. Di Costanzo, M. Gazzotti, O. Reutova, E. Usova, V. Bakaleiko, M. Arca, L. D'Erasmo, F. Pellegatta, F. Galimberti, E. Olmastroni, A. Catapano, M. Casula
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
2024 M. Janneke W C M, T. Tycho R, A. Mutaz, B. Dirk J, C. Krysztof, C. Marina, D. Laura, G. Antonio, H. G Kees, K. Ngoc Thanh, L. Jiang, R. Frederick J, S. Willemijn A M, S. Handrean, T. Thanh-Huong, B. Eric, R.V.L. Jeanine E, H.F.H.I.C.C.M. D Alareedh, R. Alieva, M. Allevi, B. B Altunkeser, K. Al-Waili, A. F Al-Zamili, M. Arca, L. Atzori, M. Averna, M. H Ayesh, S. T Azar, G. Banderali, F. Baratta, A. Bartuli, S. Béliard, V. Bianconi, S. Bini, K. Bin Thani, F. F Bitar, V. Blaha, K. Bonomo, M. Bourbon, A. Branchi, J. A Brothers, E. Bruckert, L. R Brunham, P. Bruzzi, M. Bucci, P. S Buonuomo, P. Calabrò, S. Calandra, F. Carubbi, D. Cassiman, M. Casula, A. L Catapano, F. Cavalot, A. B Cefalù, A. Cesaro, R. Ceska, M. Charng, F. Cipollone, H. Cohen, S. D'Addato, B. Dal Pino, E. J Dann, J. C Defesche, M. Del Ben, S. Demircioglu, O. S Descamps, A. Di Costanzo, M. D Di Taranto, D. Do, R. Durst, J. Dvorakova, C. F Ebenbichler, A. Elis, S. Emil, M. V Ezhov, A. C Fahed, T. Fasano, C. Ferri, F. Fogacci, E. Formisano, G. Fortunato, G. A Francis, T. Freiberger, F. Galimberti, I. M Gaspar, J. Genest, M. Gentile, A. Giammanco, C. Gokce, S. Greber-Platzer, L. Grigore, U. Groselj, M. Harada-Shiba, M. L Hartgers, R. A Hegele, P. Horak, M. Hori, L. C Hudgins, O. Hussein, G. Iannuzzo, O. Ilhan, L. Iughetti, M. Kayikcioglu, L. G Kaynar, B. A Kennedy, W. Khovidhunkit, G. Kolovou, M. Kose, I. Kuku, E. Kurtoglu, K. S Lalic, H. Le, T. Le, E. Leitersdorf, E. Liberopoulos, A.R. M Lyons, R. Madriz, G. Mandraffino, M. Mäser, R. Mehta, O. Mitchenko, G. Mombelli, T. Montalcini, C. Morace, E. M Moubarak, S. Muntoni, T. A Naguib, F. Nascimbeni, H. Nawawi, G. Nemer, M. T Nguyen, S. Notargiacomo, H. Okutan, O. I Ozcebe, J. Pang, A. Passaro, C. Pavanello, L. Pecchioli, V. Pecchioli, C. Pederiva, Z. Pekkolay, F. Pellegatta, S. Piro, M. Pirro, L. Pisciotta, A. Pujia, K. K Ray, A. Reda, M. Doortje Reijman, Ž. Reiner, S. H Rhadi, L. Rizzi, A. Romandini, I. Ruel, D. Rymen, F. Sadiq, S. Sag, O. Z Salcioglu, R. D Santos, J. M Sanz, R. Sarzani, F. Sbrana, D. Schurr, R. Scicali, N. Setia, F. K Shaghee, A. Shek, M. H Sherman, V. Soska, C.A. T Stevens, E.S. G Stroes, T. M Stulnig, P. Suppressa, A. V Susekov, P. Tarugi, A. Temizhan, L. Tichy, C. Trenti, T. R Tromp, R. Urbanek, A. J Vallejo-Vaz, H. Vaverkova, I. C Verma, M. Vrablik, L. Wang, G. F Watts, J. P Werba, A. Wiegman, P. Witters, M. Yenercag, M. Yilmaz, H. Yilmaz Yasar, A. Zambon, S. Zambon, S. Zemek, M. G Zenti, L. Zlatohlavek, L. Zuurbier
Effect on C‐reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: A network meta‐analysis
2024 S. Xie, F. Galimberti, E. Olmastroni, A.L. Catapano, M. Casula
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review
2024 E. Olmastroni, S. Scotti, F. Galimberti, S. Xie, M. Casula
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group
2022 C. Pederiva, M.E. Capra, G. Biasucci, G. Banderali, E. Fabrizi, M. Gazzotti, M. Casula, A.L. Catapano, M. Arca, M. Averna, S. Bertolini, S. Calandra, P. Tarugi, F. Pellegatta, A. Marcello, A. Maurizio, B. Andrea, B. Giacomo, B. Claudio, C. Paolo, C. Francesca, C. Francesco, C. Nadia, Maria Del Ben, F. Giuliana, G. Ornella, I. Arcangelo, I. Gabriella, I. Lorenzo, M. Giuseppe, M. Lorenzo, G.G. Mombelli, M. Sandro, P. Gianfranco, P. Angelina, C.A. Pederiva, P. Livia, P. Arturo, P. Francesco, Anna Rita Roscini, S. Riccardo, S. Patrizia, Josè Pablo Werba, Z. Sabina, Maria Grazia Zenti, A. Massimiliano, A. Renata, B. Davide, B. Giuseppe, B. Patrizia, B. Marco, Paola Sabrina Buonuomo, Angelo Baldassarre Cefalù, C. Giuseppe, D. Sergio, Maria Donata Di Taranto, F. Roberto, F. Fabio, G. Simonetta, G. Liliana, L. Graziana, M. Sara, G. Massini, M. Ilenia, M. Tiziana, N. Fabio, C. Pavanello, Francesco Massimo Perla, P. Gaia, S. Elena, S. Roberto, T. Arianna, Giovanni Battista Vigna, Z. Alberto, M. Casula, F. Galimberti, M. Gazzotti, E. Olmastroni, V. Zampoleri
Statin use and risk of dementia or Alzheimer's disease : a systematic review and meta-analysis of observational studies
2022 E. Olmastroni, G. Molari, N. De Beni, O. Colpani, F. Galimberti, M. Gazzotti, A. Zambon, A.L. Catapano, M. Casula
Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy
2022 F. Galimberti, M. Casula, L. Scotti, E. Olmastroni, D. Ferrante, A. Ucciero, E. Tragni, A.L. Catapano, F. Barone-Adesi
Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy's first wave of the COVID-19 pandemic
2022 E. Olmastroni, F. Galimberti, A. Catapano, E. Tragni, M. Casula
Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study
2020 M. Casula, E. Olmastroni, F. Galimberti, E. Tragni, G. Corrao, L. Scotti, A.L. Catapano
Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study
2020 V. Russo, V. Orlando, V.M. Monetti, F. Galimberti, M. Casula, E. Olmastroni, E. Tragni, E. Menditto
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study
2020 M. Casula, E. Menditto, F. Galimberti, V. Russo, E. Olmastroni, L. Scotti, V. Orlando, G. Corrao, A.L. Catapano, E. Tragni
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
2020 M. Casula, E. Olmastroni, M. Gazzotti, F. Galimberti, A. Zambon, A.L. Catapano